Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04517695 · ClinicalTrials.gov registry record
Blood Volume Assessment in COVID-19 and Bacterial Sepsis
A clinical trial of COVID-19 and Acute Respiratory Distress Syndrome, sponsored by NYU Langone Health.
- Completed
- Registry status
- 39
- Enrollment target
- 3
- Study locations
NCT04517695: Completed study of COVID-19 and Acute Respiratory Distress Syndrome, sponsored by NYU Langone Health.
NCT04517695 is a study of COVID-19 and Acute Respiratory Distress Syndrome that has completed, run by NYU Langone Health. The registered enrollment target is 39 participants, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04517695, a study of COVID-19 and Acute Respiratory Distress Syndrome, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
- 3
- Study locations
Study Summary
In patients with SARS-CoV-2 or bacterial infection admitted to the intensive care unit (ICU), the state of the intravascular volume, the characteristics of the blood volume components, and the development of a vascular leak is currently unknown. The relationship of these parameters with parameters of cardiac performance, lung edema and sublingual microcirculatory perfusion parameters have never been studied.
Primary Outcome
Absolute total blood volume calculated using BVA-100 software.
Conditions Studied
Interventions
- DEVICE BVA-100
- DEVICE Transpulmonary Thermodilution (TPTD)
- DEVICE Sublingual Microcirculation
Study Locations (3)
Maryland
- Uniformed Services University of the Health Sciences - Bethesda
New York
- NYU Langone Health - New York
North Carolina
- Wake Forest Baptist Health - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2023-04-09 |
What the finished NCT04517695 record still lists
NCT04517695 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with COVID-19 appearing as the primary indexed condition, and to 3 interventions - of which BVA-100 is the first listed.
NCT04517695 reports a single indexed study location in Maryland, New York, North Carolina.
Frequently Asked Questions
What is clinical trial NCT04517695 about?
NCT04517695 is a clinical study titled "Blood Volume Assessment in COVID-19 and Bacterial Sepsis". In patients with SARS-CoV-2 or bacterial infection admitted to the intensive care unit (ICU), the state of the intravascular volume, the characteristics of the blood volume components, and the development of a vascular leak is currently unknown. The relationship of these parameters with parameters o...
What is the current status of trial NCT04517695?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2020-08-01. Estimated completion is 2023-04-09.
What conditions does trial NCT04517695 study?
This clinical trial studies the following conditions: COVID-19, Acute Respiratory Distress Syndrome, Bacterial Infections, Bacterial Sepsis.
What interventions are being tested in trial NCT04517695?
The interventions under investigation include: BVA-100 (DEVICE), Transpulmonary Thermodilution (TPTD) (DEVICE), Sublingual Microcirculation (DEVICE).
Who is sponsoring clinical trial NCT04517695?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04517695 being conducted?
This trial has 3 study locations across Maryland, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04517695's enrollment target sits among peer trials
39 260th of 298 higher than 39 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI